Unilife to build syringes facility in Pennsylvania
The 15,500m2 development is projected to be operational by late 2010
Unilife Medical Solutions is to construct a new global headquarters and commercial production facility for syringes in York, Pennsylvania, US. The 15,500m2 development is projected to be operational by late 2010.
The facility will be developed on a 150,000m2 parcel of industrial land with an expected total project cost of US$26m, which will be funded by a combination of debt and cash reserves.
The plant will accommodate Unifill automated assembly lines with a combined annual capacity of 360 million units per year, as well as the Unitract 1mL automated assembly line and other contract manufacturing systems currently situated at Unilife's Lewisberry facility. It will also include a 5m2 office section that will function as Unilife's global headquarters and support administrative, marketing, new product development, quality laboratories and other operational functions.
Unilife says there is room on the site to add a further 9,200m2 of production space at a later date. This will provide the company with the necessary space to produce up to one billion syringes per annum through installation of additional Unifill assembly lines.
"Our new global headquarters and production facility will give us the required flexibility rapidly to expand our business as we move towards a NASDAQ listing, commercial production and the signing of supply agreements with current and future pharmaceutical customers,' said Unilife ceo Alan Shortall.
Unilife is an ISO 13485 certified designer and supplier of safety medical devices.